SCHLEIFER LEONARD S 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
SCHLEIFER LEONARD S
DirectorBd. Co-Chair, President & CEO
Transactions
- Sale
Common Stock
[F1][F2]2024-06-06$1015.02/sh−787$798,821→ 64,198 total(indirect: By Trust)
Holdings
- 466,877
Common Stock
- 157,552(indirect: 2023 GRAT)
Common Stock
- 5,932(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- [F2]Represents volume-weighted average price of sales of 787 shares of Company stock on June 6, 2024 at prices ranging from $1,015.00 to $1,015.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 6, 2024 at each separate price.
Signature
/s/**Leonard S. Schleifer|2024-06-10